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Abstract  Psychological mood or distress in patients with systemic sclerosis (SSc) is 
only weakly related to physician-assessed disease severity, self-reported symptoms 
and physical functioning. Psychological variables such as social support indices, 
disease-related cognitions and coping strategies are likely predictors of depressed 
mood. Until now, however, the independent association between these variables and 
psychological mood in patients with SSc after controlling for disease severity, 
symptoms and functioning has not been studied. One hundred and twenty-three 
patients completed questionnaires measuring symptoms, physical functioning, social 
support, cognitions, coping and depressed mood. Depressed mood was measured 
using a subscale of a self-report function scale developed for patients with rheumatic 
conditions. In addition, disease severity was assessed by a rheumatologist. In the final 
analysis, being married, higher levels of perceived potential support and higher levels 
of disease-related cognition acceptance each showed independent associations with 
lower levels of depressed mood after controlling for disease severity, self reported 
symptoms and function. Expression of emotion showed associations with higher 
levels of depressed mood. These findings suggest that psychological interventions in 
SSc should try to improve social support skills and acceptance of the disease by the 
patient. 
 
Running head: Predictors of Depressed Mood in Systemic Sclerosis.  
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Introduction 
Systemic Sclerosis or scleroderma (SSc) is a generalized progressive disorder of 
connective tissue that affects skin, joints, tendons and internal organs. The hallmark 
feature of the disease is the thickening of the skin (Varga & Korn, 2004). Although 
SSc runs a variable course, it has serious consequences in many patients. The fibrotic 
process (‘thickening’) may affect every internal organ and leads to morbidity and 
decreased life expectancy. Especially in patients diagnosed with diffuse cutaneous SSc 
with associated early internal organ involvement, the prognosis is poor (Medsger, 
2003). In SSc, patients report a wide range of adverse symptoms, including pain and 
tiredness. The disease has an impact on many dimensions of life (Suarez-Almazor et 
al., 2007; Haythornthwaite et al., 2003; Joachim & Acorn, 2003), including physical 
functioning (Del Rosso et al., 2004; Merkel, 1998), body image satisfaction (van 
Lankveld et al., 2007; Benrud-Larson et al., 2003; Malcarne et al., 1999), sexuality 
(Saad & Behrend, 1996), employment levels (Mau et al., 2005) and life expectancy 
(Ioannidis et al., 2005). Therefore, health-related quality of life as perceived by 
patients with SSc is significantly impaired when compared with healthy controls 
(Hyphantis et al., 2007). Furthermore, patients report problems in adjusting to the 
disease (Malcarne et al., 2007). As yet, medical treatment has only a limited effect on 
disease progression and symptom manifestation. As a result, SSc is a highly 
distressing disease to the patient. Half of the patients show mild to severe depression 
(Thombs et al., 2007; Daniele et al., 2005; Angelopoulos et al., 2001; Roca et al., 
1996) and the urgency of treating the symptoms of depression in SSc is increasingly 
recognized (Benrud-Larson et al., 2003; Matsuura et al., 2003).  
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Previous research has demonstrated that psychological mood in patients with 
SSc is only partly explained by disease status, expressed in either physician-assessed 
disease severity, self-reported symptoms or physical functioning (Nietert et al., 2005; 
Roca et al., 1996). Lazarus and Folkman (1984) defined a stress-and-coping model 
that has been successfully used to study the relation between stressful events and 
depressed mood. In this model, depressed mood is predicted by coping resources, 
cognitive appraisals and the use of coping strategies.  
In SSc, social support has been identified as an important coping resource. 
For instance, perceived adequacy of social support (Roca et al., 1996) and 
dissatisfaction with social support (Moser et al., 1993) have been shown to be 
associated with psychological mood. The interaction between these coping resources 
and the stressful event determines the patient’s appraisal of the situation: the way 
patients perceive and think about their disease. Usually, appraisals refer to how a 
person perceives the threat of the disease in relation to their coping resources. Because 
of the adverse symptoms and negative impact on many dimensions of life, SSc is 
initially perceived as a threat. However, in chronic conditions, the appraisal of the 
situation can change over time as patients learn to use new coping resources and new 
coping skills. Therefore, patients differ in the extent to which they have negative, 
neutral, or even positive cognitive appraisals about their condition (Evers et al., 2001). 
The way patients perceive and think about their disease is associated with 
psychological mood. For instance, helplessness, a negative appraisal of the disease, is 
related to higher levels of depressed mood in SSc (Matsuura et al., 2003) while the 
opposing control appraisals are related to lower levels of depressed mood (Malcarne 
& Greenbergs, 1996). The interaction between the stressful event, availability of 
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coping resources and the patient’s evaluation of the disease determines the coping 
behavior. Coping is defined as the conscious effort to deal with a stressful event, for 
instance a chronic disease. In SSc, the way patients cope with their disease is related 
to depressed mood (Malcarne & Greenbergs, 1996), with active coping strategies 
reducing the levels of depressed mood.  
These psychological variables predicting depressed mood (i.e., social 
support, cognitions and coping) are largely unrelated to clinical disease status in SSc 
(Matsuura et al., 2003; Moser et al., 1993). Furthermore, studies in rheumatoid 
arthritis (RA) have shown that psychological interventions can improve perceived 
social support, improve the use of ‘adaptive’ cognitions and improve coping skills, 
with positive effects for the patient’s psychological mood (Astin et al., 2002; 
Riemsma et al., 2002; Savelkoul et al., 2000). Therefore, these variables are likely 
candidates for psychological interventions aimed at reducing distressed mood in 
patients with SSc as well. To date, the relative importance of these variables in 
determining depressed mood in SSc is unclear. Previous studies of depressed mood in 
SSc have not included social support, disease related cognitions and coping effort 
simultaneously, or have failed to control for physician-assessed disease severity, self-
reported symptoms and physical functioning. 
The purpose of this study is to determine the relative importance of social 
support, disease cognitions and coping as predictors of depressed mood in patients 
with SSc after controlling for physician-assessed disease severity, self-reported 
symptoms and physical functioning. Because the disease is extremely unpredictable 
and the impact of the patient’s behavior or medical treatment on disease progression 
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and symptoms is only limited, it is expected that disease-related cognitions will be the 
most important variables associated with depressed mood.  
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Method 
Subjects 
All patients with a definitive diagnosis of SSc according to the American College of 
Rheumatology preliminary criteria for the classification of systemic sclerosis 
(Subcommittee ARA, 1980) who were being treated in the departments of 
rheumatology of the Sint Maartenskliniek and the Radboud University Medical Center 
were invited to participate in the study. Of the 138 patients invited, 123 agreed to 
participate (89%). The patients were predominantly middle-aged females (68%). Half 
of the patients (54%) were still active in the work force: either employed, studying or 
as a housewife. The majority of the patients had limited cutaneous SSc (71%), with 
29% suffering from diffuse cutaneous SSc. Esophageal involvement was common in 
this study sample and lungs were affected in 41% of the patients. Other organ 
involvement was less common: heart 9%, kidneys 5%, intestines 4% and muscles 4%. 
In 5 patients (4.2%), no organ involvement was reported. These findings are similar to 
sample descriptions in other studies on SSc (Medsger, 2003). Further characteristics 
of the patients are given in Table I.  
 
Procedure 
All patients were sent a letter explaining the nature of the study and inviting them to 
participate. When patients agreed to participate they received a questionnaire at their 
next physical assessment by the rheumatologist. Participants were asked to complete 
the self-reported measures and return it by mail within two weeks in a postage-paid 
return envelope.  
The study was approved by the local ethics commission. 
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Measures 
Demographic variables. Patients reported their gender, age, years of education, 
marital status, work status and disease duration (see Table I). 
Disease severity. The rheumatologist assessed three clinical variables: 1) subtype of 
SSc (limited versus diffuse cutaneous); 2) the extent and degree of skin involvement 
using the modified Rodnan Skin Score (mRSS) (Clements et al., 1993); and 3) the 
number of internal organs involved. The mRSS is obtained by clinical palpation of 17 
body areas to assess the extent and severity of skin thickening for that particular area 
on a scale from 0 to 3 (0 = normal, 1 = mild, 2 = moderate, 3 = severe). The scores are 
summed, with a possible range of 0-51; higher scores indicate more severe disease. 
The number of internal organs involved is the third clinical variable and was derived 
from a database containing all yearly assessments of our multicenter Scleroderma 
Cohort. Involvement of internal organs was assessed based on clearly defined criteria 
(Giordano et al., 1986; Altman et al., 1991; Bulpitt et al., 1993). Assessments included 
detailed patient history, physical examination, pulmonary function test, HR-CT-scan, 
echocardiography and laboratory tests.  
Physical Functioning. The validated official Dutch version of the Health Assessment 
Questionnaire (HAQ) was used to measure the patient’s physical functioning (Broers 
et al., 2007). The HAQ is a frequently used function index in rheumatology research 
that was originally developed for patients with rheumatoid arthritis (RA) (Fries et al., 
1980). More recently, the HAQ-DI has demonstrated good reliability and validity in 
patients with SSc as well (Smyth et al., 2003; Steen & Medsger, 1997; Pool & Steen, 
1991). The Disability Index of this self-reported measure consists of 20 items 
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measuring 8 dimensions of functioning: dressing and grooming, arising, eating, 
walking, personal hygiene, reach, grip strength, and activities. The score for each 
dimension ranges from 0 (best function) to 3 (worst function). In addition to separate 
scores on the 8 dimensions, mean scores for these 8 HAQ scores are calculated and 
used as an indicator of overall physical functioning (HAQ-DI). The HAQ-DI showed 
good internal consistency is this sample (Cronbach’s Alpha = .90). 
Disease Symptoms. The symptoms of SSc were assessed using the SHAQ (Steen & 
Medsger, 1997). The SHAQ comprises the HAQ and six additional Visual Analog 
Scales measuring the severity of disease symptoms. The different scales measure the 
subjective severity of the symptoms due to internal organ involvement, Raynaud’s 
phenomenon, gastrointestinal involvement, lung involvement, pain, and overall 
disease severity. In the present study, we used one additional VAS measuring 
tiredness. The mean scores on the 7 VAS scales were computed and used as an 
indicator of overall perceived symptom severity.  
Psychological mood. The scale ‘Depressed Mood’ of the ‘Impact of Rheumatic 
Diseases on General Health and Lifestyle’ (Invloed van Reuma op Gezondheid en 
Leefwijze: IRGL; Huiskes et al., 1990) was used to assess depressed mood. The IRGL 
is frequently used in the Netherlands and has been shown to be a reliable and valid 
instrument for assessing physical, psychological and social functioning in patients 
with rheumatic diseases. The validity and reliability of the 6-item subscale ‘Depressed 
Mood’ has been previously studied in the Dutch population (Zwart & Spooren, 1982). 
The scale measures 6 mood states: depressed, gloomy, disheartened, low spirited, 
disconsolate and sad. Participants rate the extent to which they have experienced each 
mood state during the last week, using a 5-point Likert scale ranging from ‘not at all’ 
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to ‘a lot’. Higher scores depict higher levels of depressed mood. The scale showed 
good internal consistency is this sample (Cronbach’s Alpha = .93). 
Social support. Social support was measured using two subscales of the IRGL: 
‘Potential Support’ (5 items; e.g., ‘When I am in pain, there is someone to support 
me’) and ‘Actual Support’ (3 items; e.g., ‘I speak confidentially with others’). Scores 
were rated on a 4-point Likert scale from ‘almost never’ to ‘almost always’. The 
reliability of these scales in this sample was good (Cronbach’s Alpha = .90 and .65, 
respectively).  
Illness Cognitions. Cognitions were assessed using the Illness Cognitions 
Questionnaire (ICQ; Evers et al., 2001). The ICQ was developed in the Netherlands 
and measures three generic illness cognitions or different disease-related connotations: 
‘Helplessness’, ‘Acceptance’ and ‘Disease Benefits’. ‘Helplessness’ emphasizes the 
negative meaning of the stressor, ’Acceptance’ diminishes the negative meaning, and 
’Disease Benefits’ gives a positive meaning to the event. The scale consists of 18 
items with six items for each of the three constructs. Item examples are: ‘My illness 
frequently makes me feel helpless’ (helplessness), ‘I have learned to live with my 
illness’ (acceptance) or ‘My illness has helped me realize what’s important in life’ 
(disease benefits). Participants were asked to indicate on a 4-point Likert scale the 
extent to which they agree with these statements, ranging from ‘not at all’ to 
‘completely’. The scale has excellent construct and internal validity (Evers et al., 
2001). The internal consistency of these scales in this sample was good (Cronbach’s 
Alpha = .88, .91 and .82 for Helplessness, Acceptance and Disease Benefits, 
respectively). Higher scores reflect higher levels of agreement with that particular 
disease connotation. 
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Coping. Coping was assessed using the Utrecht Coping Scale, which has good validity 
and reliability (UCL; Schreurs et al., 1993). The UCL measures ‘Active coping’ (7 
items), ‘Comforting cognitions’ (5 items), ‘Seeking social support’ (6 items), 
‘Avoidance’ (8 items), ‘Expression of emotions’ (3 items) and ‘Palliative reaction’ (8 
items). Respondents are asked to indicate how often they use that particular coping 
strategy when reacting to a stressful event. Answers range from 1: seldom or never, to 
4: very often. Higher scores on the coping scales depict more frequent use of the 
coping style. In this sample, the different scales showed sufficient internal consistency 
(Cronbach’s Alpha between .70 and .80 for each of the scales). 
 
Statistical analysis 
Relationships between variables are expressed in Pearson correlations and partial 
correlations. Differences between groups were tested using Students t-test for 
independent samples or ANOVA. Mean scores on the different psychological 
measures were compared to mean scores reported for patients with rheumatoid 
arthritis (RA). RA is also a painful, chronic and progressive rheumatologic condition. 
Separate regression analyses were performed to determine the relation between social 
support, cognition and coping variables with depressed mood. The stress-coping 
model of Lazarus and Folkman determines the order in which selected variables are 
entered into the model predicting depressed mood. To this end, a hierarchic regression 
analysis was performed, with selected variables entered as blocks and depressed mood 
as the dependent variable. First, physician-assessed disease severity variables were 
forced into the equation as a block, followed by a block of self-reported functioning 
and symptoms. Because it is argued that demographic and social support measures are 
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part of the person’s resources, these variables will in part determine the patient’s 
cognitions and coping, and should thus be controlled for. Therefore, demographic and 
social support measures with a significant association with depressed mood were 
entered next. Finally, significantly related cognitions and coping variables were 
entered blockwise. For each block, the amount of variance explained by that block is 
given (R2 change). To explore the relative contribution of the potential predictors of 
depressed mood, standardized regression coefficients are calculated (Beta weights). 
These Beta weights depict the relative importance of each variable in explaining 
depressed mood while controlling for all the other independent variables entered in 
the analysis. Statistics were calculated using the SPSS, version 9.1. Significance levels 
were set at p < .05.  
 
Results 
Associations between depressed mood and demographic characteristics, disease 
severity, self-reported symptoms and physical functioning 
The mean score for depressed mood in this SSc patient sample was 4.6 (SD = 4.5), 
reflecting mild symptoms of depressed mood. Similar levels of depressed mood were 
reported in a sample of RA outpatients (M = 4.3, SD = 4.5; mean difference = 0.3, not 
significant) and lower levels of depressed mood were reported in healthy adults (M = 
1.47, SD = 2.57; t (1,122) = 6.62, p < .01) (Huiskes et al., 1990). Clinical and 
subclinical depression was present in 49% of the patients. Subclinical depression is 
defined as a score greater than 4 on the scale for depressed mood (Zwart & Spooren, 
1982). These findings are in line with the levels of depression reported in other 
studies. A recent review of eight studies on depression in SSc concluded that 36-65% 
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of patients had clinically significant symptoms of depression (Thombs et al., 2007). 
No significant correlations were found between disease duration, years of education, 
work status and depressed mood. Marital status was the only demographic variable 
related to depressed mood. Thus, married patients reported lower levels of depressed 
mood compared to either unmarried, divorced or widowed patients (mean scores 3.9, 
6.4, 7.8 and 6.8, respectively; ANOVA for difference between groups: F (3,117) = 5.6, 
p < .05). For subsequent analysis, this variable was dichotomized (married, not 
married).  
Clinical disease severity was unrelated to depressed mood. Patients with 
limited SSc did not differ from patients with diffuse cutaneous SSc in depressed 
mood; the mean scores (with standard deviation in parenthesis) were 4.5 (4.7) and 4.8 
(4.3), t(122) = 0.3, not significant. The correlations between modified mRSS or 
number of organs involved (summation of affected organs) and depressed mood were 
not significant (r = .09 and .10, respectively). 
The mean scores and standard deviation (SD) of self-reported disease 
symptoms and physical functioning measures, as well as the Pearson correlations with 
depressed mood, are presented in Table II.  
Self-reported symptoms are associated with depressed mood. Six of the 7 
VAS were significantly correlated with depressed mood. Only the VAS measuring 
ulcers was unrelated to depressed mood. Tiredness showed the highest mean VAS 
score of all the self-reported disease symptom scales. The high correlation between 
tiredness and depressed mood was similar to the strength of the correlation reported 
between depressed mood and pain or self-reported disease severity. In a regression 
analysis, the group of disease symptom scales together explained an additional 32% of 
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the variance in depressed mood after controlling for dichotomized marital status 
(F(7,109) = 7.6, p < .001). Self-reported functioning was related to depressed mood in 
a similar way. Each HAQ subscale was significantly correlated with depressed mood. 
Together, the combined function scales explained 24% of the variance in depressed 
mood after controlling for marital status (F(8,108) = 5.27, p < .001). Both higher 
levels of perceived disease symptoms and impaired physical functioning are 
associated with higher levels of depressed mood. High correlations were observed in 
both the set of self-reported symptom scales and physical function scales (correlations 
ranging from .25 to .72). Therefore, both the mean score computed for the disease 
symptom scales and the mean score for the physical function scores were used in 
further analysis.  
Associations between depressed mood and social support, cognitions and coping 
The mean scores for social support, disease cognitions and coping, as well as the 
Pearson correlation and partial correlation of each variable with depressed mood, are 
shown in Table III. Partial correlations were computed while controlling for marital 
status, mean self-reported symptom score and mean functional limitation.  
The mean scores found for social support measures and coping in this sample 
were similar to the mean scores reported in patients with RA (Huiskes et al., 1990). 
The mean scores on the disease cognitions ‘helplessness’ and ‘disease benefits’ also 
equaled those reported in RA (Evers et al., 2001). The mean levels of acceptance in 
SSc and RA (with standard deviations in parenthesis) were 15.3 (4.3) and 16.7 (4.2), 
respectively. Patients with SSc reported lower levels of acceptance compared to 
patients with RA t(1,389)  = 2.9, p < .05. A significant negative correlation between 
Potential Support and depressed mood was found. This correlation remained 
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significant after controlling for marital status, disease symptom and functioning. 
Higher levels of Potential Support were associated with lower levels of depressed 
mood. Actual support was unrelated to depressed mood. Helplessness and Acceptance 
both showed strong correlations with depressed mood. Higher levels of ‘helplessness’ 
were associated with higher levels of depressed mood, while acceptance was 
associated with lower levels of depressed mood. Both associations remained 
statistically significant after controlling for marital status, mean disease symptoms and 
functioning. Within the third group of potential predicting variables, only two coping 
styles were significantly related to depressed mood: Active Coping was associated 
with lower levels of depressed mood and Expression of emotions was associated with 
higher levels of depressed mood. Both correlations remained significant after 
controlling for marital status, symptoms and functioning.  
Stepwise regression analysis predicting depressed mood 
Next, we selected the psychological variables that showed significant partial 
correlations with depressed mood for the final analysis to explore their relative 
contribution to the prediction of depressed mood after controlling for physician-
assessed disease severity, self-reported symptoms and physical functioning. The result 
of the hierarchic stepwise regression analysis of depressed mood is shown in Table 
IV, with the variables entered in blocks. In the first block, physician-assessed disease 
severity variables are entered: subtype of SSc, Rodnan Skin Score and number of 
internal organs involved. Next, self-reported disease symptoms and physical 
functioning are forced into the equation as a block, followed by Marital Status (block 
3) and Potential Support (block 4). Marital status and Potential Support are unrelated 
in this sample, i.e., married patients did not differ in potential support from patients 
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that were not married. Next, the disease cognitions Helplessness and Acceptance were 
entered as a block. In the last step, the coping styles Active Coping and Expression of 
Emotions were entered as a block. For each block, the increase in the percentage of 
variance, R2, and the standardized Beta weights are given. These Beta weights reflect 
the relative importance of all the variables entered in the final model, and the direction 
of the association with depressed mood. Because these Beta weights are standardized, 
the relative importance of the different variables in predicting depressed mood can be 
compared on the basis of these Beta weights. 
The first block of physician-assessed disease severity was unrelated to 
depressed mood (F(3,119) = 0.7, not significant). The block of self-reported disease 
symptoms and physical functioning together explained an additional 25% of the 
variance in depressed mood after controlling for physician-assessed disease severity 
(F(5,117) = 8.6, p < .01). Marital status explained a further 8% of the variance in 
depressed mood (F(6,116) = 10.5, p < .01) and an additional 4% was explained by 
Potential Support (F(7,115) = 10.4, p < .01). The two disease cognitions entered 
together as a block in step four of the equation explained an additional 10% of the 
variance in depressed mood (F change (9,113) = 12.0, p < .01). The last block to be 
entered, consisting of both coping styles, explained another 6% (F change(11,111) = 
12.0, p < .01). The final model explained 54% of the variance in depressed mood (F 
(11,111) = 16.4, p < .001). The Beta Regression weights indicated that in the final 
model, higher levels of disease symptoms and expression of emotions were associated 
with higher levels of depressed mood. Being married and higher levels of potential 
support and acceptance were associated with lower levels of depressed mood.  
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Discussion 
The aim of this study was to determine the relative importance of social support, 
disease cognitions and coping in predicting depressed mood in patients with SSc after 
controlling for physician-assessed disease severity, self-reported symptoms and 
functioning. As expected, disease-related cognitions showed the strongest associations 
with depressed mood in SSc, but individual social support and coping indices were 
also related to depressed mood.  
The levels of depressed mood in this SSc patient population were elevated 
compared to the general population, and equaled the levels of depressed mood 
previously observed in patients with RA (Huiskes et al., 1990) and SSc (Thombs et 
al., 2007). In agreement with previous findings, depressed mood was largely 
independent of clinical disease severity (Daniele et al., 2005; Nietert et al., 2005; Roca 
et al., 1996). However, strong associations were found between depressed mood and 
both self-reported disease symptoms and physical functioning.  
The VAS Tiredness included in this study seems to be an important addition 
to the 6 symptom scales of the SHAQ (Steen & Medsger, 1997). The mean VAS score 
for tiredness was higher than the VAS score on any of the other symptom scales. 
These results confirm the recently reported importance of tiredness as a symptom in 
SSc (Richards et al., 2003). Tiredness was strongly associated with depressed mood in 
this sample. Tiredness is known to be associated with depression and with disease 
activity in other autoimmune and rheumatic diseases. Therefore, more research is 
needed to distinguish between these concepts and to determine the relative importance 
of disease activity and depressed mood in tiredness. Nevertheless, tiredness is an 
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important symptom in SSc and should be assessed in order to fully comprehend the 
impact of the disease.  
More importantly, this study demonstrates that perceived social support, 
disease cognitions and coping are associated with depressed mood in patients with 
SSc, even after controlling for physician-assessed disease severity as well as self-
reported disease symptoms and physical functioning. Potentially, each of these 
psychosocial variables can be targeted in psychological interventions, improving 
depressed mood. In line with previous research, this study confirms the importance of 
social support (Roca et al., 1996; Moser et al., 1993). However, the level of actual 
support is not correlated with depressed mood. This last finding should be interpreted 
with caution. The Cronbach’s alpha of the actual support scale used in this study was 
low at 0.65. The low internal consistency of this measure may have contributed to the 
lack of significant association between actual support and depressed mood. A more 
internally consistent measure of actual support might show a different relationship 
with depressed mood. In this study, however, it is potential support, or the confidence 
that one can turn to another person for help, that is associated with lower levels of 
depressed mood. Potential support is a cognitive evaluation of social support 
resources. Interestingly, this relationship is independent of marital status. However, 
both marital status and potential support are associated with depressed mood. Further 
research is needed to clarify the interaction between marital status, social support and 
depressed mood in patients with SSc.  
Of all the psychological variables included in the study, ‘helplessness’ and 
‘acceptance’ showed the strongest correlations with depressed mood. Moreover, these 
disease cognitions entered as a block in a regression analysis made a significant 
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contribution to the prediction of depressed mood (explaining an additional 10% of the 
variance) after controlling for physician-assessed disease severity, self-reported 
disease symptoms, physical functioning, marital status and social support. Therefore, 
it seems that both negative (helplessness) and neutralizing (acceptance) connotations 
concerning the disease are related to depressed mood. However, ‘helplessness’ made 
no independent unique contribution to the prediction of depressed mood in the final 
analysis, over and above all other variables in the final equation. Furthermore, positive 
cognition (disease benefits) is unrelated to depressed mood. It is still unclear how this 
lack of association between disease benefits and depressed mood should be explained. 
Previous studies confirmed the importance of the cognitive appraisals of helplessness 
and control (Matsuura et al., 2003; Malcarne & Greenbergs, 1996). Neutral and/or 
positive cognitive re-evaluations have not previously been studied in SSc, although 
one study showed that a related construct, sense of coherence, was inversely related to 
depression (Matsuura et al., 2003). However, ‘sense of coherence’ refers to a 
personality trait and less to disease-related cognitions as conceptualized in this study. 
Acceptance as measured in this study refers to attaching connotations to an event that 
diminish the negative meaning of the stressful event (Evers et al., 2001). As such, 
these connotations can be modified by psychological interventions.  
Only two of the coping strategies measured in this study were related to 
depressed mood: active coping and expression of emotions. The significant partial 
correlations between these two coping strategies and depressed mood indicate that 
these relations remained significant after controlling for marital status, self-reported 
disease symptoms and physical functioning. The association between active coping 
and depressed mood is similar to the relationship between problem-focused coping 
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and distress reported by Malcarne & Greenbergs (1996). Both coping scales measure a 
conceptually similar construct. Active coping or problem-focused coping thus seems 
to have some positive effect in patients with SSc. In this study, however, active coping 
made no independent unique contribution to the prediction of depressed mood, 
beyond social support and disease cognitions. The relationship between expression of 
emotions and higher levels of depressed mood observed in this study is remarkable. 
Expression of emotions is generally regarded as a positive coping style with potential 
positive effects for a person’s psychological mood (Gohm & Clore, 2002). However, 
expression of emotions can also be seen as a primarily emotion-focused coping 
strategy. In general, emotion-focused coping strategies are associated with negative 
consequences for a person’s well-being. Further research is needed to understand the 
relation between expression of emotions and depressed mood in patients with SSc. To 
summarize, ‘potential support’ and ‘acceptance’ are both related to lower levels of 
depressed mood, while ‘helplessness’ and ‘expression of emotions’ are positively 
associated with depressed mood.  
Several limitations of this study should be mentioned. First of all, in the 
current study, only generic psychological measures were used, i.e., instruments 
measuring psychological factors that play a role in all chronic diseases. Some SSc-
specific factors may contribute to perceived psychological distress as well. For 
instance, skin modification is a stressor that is specific for SSc. Indeed, some studies 
have pointed out the importance of body-image dissatisfaction in the patient’s 
psychological well-being (Benrud-Larson et al., 2003; Ben-Tovim & Walker, 1995). 
The SHAQ questionnaire, measuring the perceived severity of the disease symptoms, 
does not contain a scale ‘skin modification’ or a conceptually related construct. Skin 
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modification may be extremely negative and psychologically distressing for the 
individual patient (van Lankveld et al., 2007). Psychological treatment should address 
these individual problems when appropriate. The correlational design of the current 
study is another limitation. As yet, no longitudinal studies have been conducted into 
the long-term effects of social support, coping and cognitions on depressed mood in 
SSc.  
Nonetheless, these findings may have important implications for the future 
treatment of depressed mood in patients with SSc. Although the mean score for 
depressed mood in SSc is high, no studies heave been reported on the effectiveness of 
psychological interventions in reducing depressed mood in SSc. Recently, some 
interventions have been developed based on educational principles (Samuelson & 
Ahlmén, 2000; Genth & Baltscheit, 2003). The primary goal of these interventions is 
to educate the patient about the disease, and not primarily to improve the patient’s 
depressed mood. However, given the high levels of depression in these patients, 
specific interventions to reduce the patient’s level of depressed mood should be 
developed. Such specific interventions in SSc could benefit from the findings reported 
in this study. In RA, cognitive-behavioral interventions are effective in improving the 
patient’s psychological well-being (Riemsma et al., 2002). This is true for 
interventions targeting the patients coping and those targeting cognitions (van 
Lankveld et al., 2004), as well as for interventions aimed at improving the patient’s 
social support skills (Savelkoul & Witte, 2004). Similar interventions in SSc may help 
reduce depressed mood as a result of the disease. More research is needed to 
determine whether an intervention targeting the psychological associates of depressed 
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mood identified in this study will actually result in improved psychological well-being 
of patients with SSc. 
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Table I: Demographic characteristics and physician-assessed disease severity of 
patients with SSc (N = 123). 
 
 
Age in years (mean (SD))   54.3 (12.9)  
Female %   68.0% 
Education  
 < 9 years   9.0% 
 9-14 years   71.0% 
 15-17   14.5% 
 > 18   4.9% 
Work Status 
 Student   1.6% 
 Employed   23.2% 
 Housekeeping   26.4% 
 Social benefit   27.2% 
 Retired   18.4% 
Marital status 
 Never married    11.4% 
 Married   76.0% 
 Divorced   4.9% 
 Widowed   8.1% 
Duration of the disease in years (mean SD) 10.6 (9.7) 
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Physician-assessed disease severity 
 Patients with limited SSc   71% 
 Mean mRSS   9.9 (7.6) 
 Number of organs involved  1.5 (0.7) 
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Table II:  Mean scores on Perceived Disease Symptoms and Physical Functioning in 
the sample and Pearson correlations with Depressed Mood (N = 123). 
 
            
  Range              Mean (SD)     Depressed Mood                           
                                                            r 
Disease symptoms (VAS) 0-10   
 Pain  3.4 (2.7) 0.45** 
 Intestine   1.8 (2.2) 0.29** 
 Breath  3.2 (3.1) 0.28** 
 Raynaud’s  4.3 (3.1) 0.32** 
 Digital Ulcers  2.9 (3.9) 0.16 
 Disease severity  4.0 (2.6) 0.51** 
 Tiredness  4.8 (2.7) 0.46** 
 Mean Symptom Score  3.4 (2.1) 0.49**  
 
Functioning (HAQ-DI) 0-3  
 
 Dressing and grooming  0.9 (0.8) 0.36** 
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 Arising  0.6 (0.7) 0.32** 
 Eating  1.1 (0.9) 0.26** 
 Walking  0.8 (0.9) 0.37** 
 Hygiene  1.1 (1.0) 0.27** 
 Reach  1.0 (0.9) 0.39** 
 Grip strength  0.9 (0.8) 0.27** 
 Activities  1.4 (0.9) 0.45** 
 Mean Function Score  1.0 (0.7) 0.44** 
 
* p < .05, ** p < .01 
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Table III:  Mean scores for Social Support, Cognitions and Coping, and 
correlations and partial correlations with depressed mood. 
·     
                                                 Range Mean (SD)                 r                 partial r #          
     
  
Social support (IRGL a)     
 Potential support 5-20 15.3 (4.1) -0.32** -0.25* 
 Actual support 3-12 6.7 (1.8) -0.06 -0.09 
Cognitions (ICQ b)     
 Helplessness 4-24 13.4 (4.6) 0.54** 0.31** 
 Acceptance  4-24 15.3 (4.3) -0.56** -0.40** 
 Disease benefits  4-24 14.5 (4.0) -0.18 -0.19 
Coping (UCL c)      
 Active coping 7-28 17.6 (3.6) -0.31** -0.30** 
 Comforting Cognitions 5-20 13.5 (2.6) -0.12 -0.17 
 Seeking Social Support 6-24 12.8 (3.3) 0.06 0.03 
 Avoidance 8-32 16.3 (3.1) 0.12 0.08 
 Expression of emotions 3-12 6.0 (1.8) 0.33** 0.32** 
 Palliative reaction 8-32 17.6 (3.6) 0.14 0.02 
 
#Controlling for marital status, self-reported disease symptoms and physical functioning. a IRGL, 
Impact of Rheumatic Diseases on General Health and Lifestyle (Invloed van Reuma op 
Gezondheid en Leefwijze); b ICQ, Illness Cognitions Questionnaire; c  UCL, Utrecht Coping Scale.  
*p < .05, ** p < .01 
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Table IV:  Stepwise regression analysis predicting Depressed Mood, entering disease 
severity variables, and selected social support, cognitions and coping variables. 
 
Step  Variables   R2 change                     betaa 
 
1 Physician-assessed disease severity .01 
Subtype SSc            .06 
Rodnan Skin Score          -.11 
Number of organs involved.         -.02 
 
2 Self-reported disease variables .26** 
                        Symptoms  .24** 
              Functioning  .09 
    3  Marital status (0 = not married, 1 = married) .08** -.24** 
    4     Potential support .04** -.16* 
    5 Disease Cognitions .10** 
              Helplessness  .14 
              Acceptance  -.18* 
6                   Coping .06** 
                                  Active Coping  -.11 
              Expression of emotions  .21** 
 
Total  R2  .54** 
a 
  Standardized regression coefficient. *p < .05, ** p < .01 
 38 
 
